An in vitro model of mycobacterial granuloma to investigate the immune response in brain-injured patients

Critical Care Medicine

Volumn 41, Issue 1, 2013, Pages 245-254

  Deknuydt, Florence ^a   Roquilly, Antoine ^a,b   Cinotti, Raphaël ^b   Altare, Frédéric ^a   Asehnoune, Karim ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

brain injury; cellular immunity; granulomas; immunosuppression; natural killer cells; nosocomial pneumonia; T cells

Indexed keywords

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GAMMA DELTA T LYMPHOCYTE; GIANT CELL; GRANULOMATOUS INFLAMMATION; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MONOCYTE; MULTINUCLEAR CELL; MYCOBACTERIUM; NATURAL KILLER CELL; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

ADAPTIVE IMMUNITY; ADULT; BRAIN INJURIES; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; FRANCE; GIANT CELLS; GRANULOMA; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; KILLER CELLS, NATURAL; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM BOVIS; PNEUMONIA, VENTILATOR-ASSOCIATED; SUBARACHNOID HEMORRHAGE; T-LYMPHOCYTES;

EID: 84872054795     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182676052     Document Type: Article

References (51)

1. Pelosi P, Ferguson ND, Frutos-Vivar F, et al; Ventila Study Group: Management and outcome of mechanically ventilated neurologic patients. Crit Care Med 2011; 39:1482-1492
2. Osborn TM, Tracy JK, Dunne JR, et al: Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 2004; 32:2234-2240
3. Rincón-Ferrari MD, Flores-Cordero JM, Leal-Noval SR, et al: Impact of ventilator-associated pneumonia in patients with severe head injury. J Trauma 2004; 57:1234-1240
4. Bronchard R, Albaladejo P, Brezac G, et al: Early onset pneumonia: Risk factors and consequences in head trauma patients. Anesthesiology 2004; 100:234-239
5. Czaja AS, Rivara FP, Wang J, et al: Late outcomes of trauma patients with infections during index hospitalization. J Trauma 2009; 67:805-814
6. Safdar N, Dezfulian C, Collard HR, et al: Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005; 33:2184-2193
7. Woiciechowsky C, Schöning B, Lanksch WR, et al: Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med 1999; 77:769-780
8. Sarrafzadeh A, Schlenk F, Meisel A, et al: Immunodepression after aneurysmal subarachnoid hemorrhage. Stroke 2011; 42:53-58
9. Meisel C, Meisel A: Suppressing immunosuppression after stroke. N Engl J Med 2011; 365:2134-2136
10. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462
11. Cheron A, Floccard B, Allaouchiche B, et al: Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 2010; 14:R208
12. Prass K, Meisel C, Höflich C, et al: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198:725-736
13. Mrakovcic-Sutic I, Tokmadzic VS, Laskarin G, et al: Early changes in frequency of peripheral blood lymphocyte subpopulations in severe traumatic brain-injured patients. Scand J Immunol 2010; 72: 57-65
14. Wong CH, Jenne CN, Lee WY, et al: Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011; 334:101-105
15. Cheadle WG, Turina M: Infection and organ failure in the surgical patient: A tribute to seminal contributions by Hiram C. Polk, Jr, M. D. Am J Surg 2005; 190:173-177
16. Heffernan DS, Monaghan SF, Thakkar RK, et al: Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care 2012; 16:R12
17. Spruijt NE, Visser T, Leenen LP: A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients. Crit Care 2010; 14:R150
18. Venet F, Chung CS, Monneret G, et al: Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 2008; 83:523-535
19. Puissegur MP, Botanch C, Duteyrat JL, et al: An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol 2004; 6:423-433
20. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons: Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007; 24 (Suppl 1):S1-S106
21. Bederson JB, Connolly ES Jr, Batjer HH, et al; American Heart Association: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40:994-1025
22. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
23. Trouillet JL, Chastre J, Vuagnat A, et al: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
24. Roquilly A, Mahe PJ, Seguin P, et al: Hydrocortisone therapy for patients with multiple trauma: The randomized controlled HYPOLYTE study. JAMA 2011; 305:1201-1209
25. Lepelletier D, Roquilly A, Demeure dit latte D, et al: Retrospective analysis of the risk factors and pathogens associated with early-onset ventilator-associated pneumonia in surgical-ICU head-trauma patients. J Neurosurg Anesthesiol 2010; 22:32-37
26. Seguin P, Tanguy M, Laviolle B, et al: Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma. Crit Care Med 2006; 34:1514-1519
27. Meisel C, Schwab JM, Prass K, et al: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6:775-786
28. Hamada S, Umemura M, Shiono T, et al: Importance of murine Vdelta1gammadelta T cells expressing interferon-gamma and interleukin-17A in innate protection against Listeria monocytogenes infection. Immunology 2008; 125:170-177
29. Tsuji S, Matsumoto M, Takeuchi O, et al: Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette- Guérin: Involvement of toll-like receptors. Infect Immun 2000; 68:6883-6890
30. Sallusto F, Lanzavecchia A, Araki K, et al: From vaccines to memory and back. Immunity 2010; 33:451-463
31. Medzhitov R, Janeway C Jr: Innate immunity. N Engl J Med 2000; 343:338-344
32. McNally AK, Anderson JM: Macrophage fusion and multinucleated giant cells of inflammation. Adv Exp Med Biol 2011; 713:97-111
33. Russell DG, Cardona PJ, Kim MJ, et al: Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 2009; 10:943-948
34. Divangahi M, Chen M, Gan H, et al: Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol 2009; 10:899-906
35. Roquilly A, Gautreau L, Segain JP, et al: CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia. PLoS ONE 2010; 5:e13228
36. Lay G, Poquet Y, Salek-Peyron P, et al: Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake. J Pathol 2007; 211:76-85
37. Takashima T, Ohnishi K, Tsuyuguchi I, et al: Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4. J Immunol 1993; 150:3002-3010
38. Möst J, Neumayer HP, Dierich MP: Cytokine-induced generation of multinucleated giant cells in vitro requires interferon-gamma and expression of LFA-1. Eur J Immunol 1990; 20:1661-1667
39. Sun JC, Lanier LL: NK cell development, homeostasis and function: Parallels with CD8? T cells. Nat Rev Immunol 2011; 11:645-657
40. Münz C, Steinman RM, Fujii S: Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity. J Exp Med 2005; 202:203-207
41. Newton DW Jr, Runnels HA, Kearns RJ: Enhanced splenic bacterial clearance and neutrophilia in anti-NK1. 1-treated mice infected with Pseudomonas aeruginosa. Nat Immun 1992; 11:335-344
42. Wesselkamper SC, Eppert BL, Motz GT, et al: NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection. J Immunol 2008; 181:5481-5489
43. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM: Natural killer (NK) cells in antibacterial innate immunity: Angels or devils? Mol Med 2012; 18:270-285
44. Bonneville M, Scotet E: Human Vgamma9Vdelta2 T cells: Promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 2006; 18:539-546
45. Matsushima A, Ogura H, Fujita K, et al: Early activation of gammadelta T lymphocytes in patients with severe systemic inflammatory response syndrome. Shock 2004; 22:11-15
46. Bonneville M, O'Brien RL, Born WK: Gammadelta T cell effector functions: A blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10:467-478
47. Xiao W, Mindrinos MN, Seok J, et al; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm in critically injured humans. J Exp Med 2011; 208:2581-2590
48. Agbaht K, Lisboa T, Pobo A, et al: Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: Does trauma make a difference? Intensive Care Med 2007; 33:1387-1395
49. Kistowska M, Rossy E, Sansano S, et al: Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR gamma delta cells. Eur J Immunol 2008; 38:2200-2209
50. Kalyan S, Chow AW: Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1. J Infect Dis 2004; 189:1892-1896
51. Moretta A: Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat Rev Immunol 2002; 2:957-964